Most pharmacies have an overwhelming number of potential opportunities to increase performance measures. In order to stay ahead of the game and increase your bottom line, you must target the opportunities that are actually affecting your DIR fees.
Not all performance measures impact your DIR fees
Whether a clinical intervention outcome affects your pharmacy's DIR fees or not depends on the patient's current plan. Let's say one of your Medicare patients is not adherent to their cholesterol medication. If the patient is currently in an Express Scripts plan, their adherence does not impact your DIR fees! This is why.
Amplicare Impact analyzes your opportunities and identifies the ones that will directly affect your DIR fees, so you can prioritize the most important ones:
Your high priority patients
Use filters to customize your Impact reports so you target the right patients. Click the following links to see your patients that are directly impacting your DIR fees:
Access your opportunities
Go to Opportunities and select either the "Low Adherence" report or the "Gap Therapy: Statin" report in the Worklist dropdown box.
Then, click "Add Filter:"
Select the "DIR Impact" filter to identify the patients who are truly increasing your DIR fees based on their current plan's performance measurements:
You can also add an additional filter to sort by the adherence type (cholesterol, diabetes, or hypertension).
Engaging with your patients is key to successfully addressing these clinical opportunities. Once you've identified your high priority patients, print personalized handouts for each patient to help start the conversation.
Click here to learn about other best practices to successfully complete clinical interventions!